# Empire State Realty Trust, Inc.: overview

ESRT · NYSE · CIK 1541401 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esrt.md) · [Financials](/companies/esrt/financials.md) · [Filings](/companies/esrt/filings.md) · [Insiders](/companies/esrt/insiders.md)

Latest reported revenue: [$196.6m](/filings/0001541401-26-000033.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001541401-26-000033).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [199](/filings/0001541401-25-000037.md) | [197 d](/filings/0001541401-26-000008.md) | [180](/filings/0001541401-26-000020.md) | [191](/filings/0001541401-26-000033.md) | [197](/filings/0001541401-25-000037.md) | [199 d](/filings/0001541401-26-000008.md) | [190](/filings/0001541401-26-000020.md) | [197](/filings/0001541401-26-000033.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [22.7%](/filings/0001541401-25-000037.md) | [21.8% d](/filings/0001541401-26-000008.md) | [14.4%](/filings/0001541401-26-000020.md) | [18.4%](/filings/0001541401-26-000033.md) | [19.9%](/filings/0001541401-25-000037.md) | [17.8% d](/filings/0001541401-26-000008.md) | [15.5%](/filings/0001541401-26-000020.md) | [(70.5%)](/filings/0001541401-26-000033.md) |
| Net margin | % | [11.4%](/filings/0001541401-25-000037.md) | [9.5% d](/filings/0001541401-26-000008.md) | [8.8%](/filings/0001541401-26-000020.md) | [6.0%](/filings/0001541401-26-000033.md) | [6.9%](/filings/0001541401-25-000037.md) | [16.2% d](/filings/0001541401-26-000008.md) | [1.6%](/filings/0001541401-26-000020.md) | [(20.1%)](/filings/0001541401-26-000033.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001541401-25-000037.md) | not reported | [0.05](/filings/0001541401-26-000020.md) | [0.04](/filings/0001541401-26-000033.md) | [0.05](/filings/0001541401-25-000037.md) | not reported | [0.01](/filings/0001541401-26-000020.md) | [(0.15)](/filings/0001541401-26-000033.md) |
| Free cash flow | $m | [(65.1) d](/filings/0001541401-25-000037.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [624](/filings/0001541401-24-000033.md) | [726](/filings/0001541401-25-000003.md) | [738](/filings/0001541401-26-000008.md) | [767](/filings/0001541401-26-000008.md) | [767](/filings/0001541401-26-000008.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.7%](/filings/0001541401-24-000033.md) | [17.5%](/filings/0001541401-25-000003.md) | [19.9%](/filings/0001541401-26-000008.md) | [20.7%](/filings/0001541401-26-000008.md) | [17.7%](/filings/0001541401-26-000008.md) |
| Net margin | % | [(2.1%)](/filings/0001541401-24-000033.md) | [8.7%](/filings/0001541401-25-000003.md) | [11.4%](/filings/0001541401-26-000008.md) | [10.5%](/filings/0001541401-26-000008.md) | [9.5%](/filings/0001541401-26-000008.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001541401-24-000033.md) | [0.22](/filings/0001541401-25-000003.md) | [0.30](/filings/0001541401-26-000008.md) | [0.28](/filings/0001541401-26-000008.md) | [0.25](/filings/0001541401-26-000008.md) |
| Free cash flow | $m | [(186)](/filings/0001541401-24-000033.md) | [125](/filings/0001541401-25-000003.md) | [63.3](/filings/0001541401-26-000008.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/esrt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $96.7m | 17,877,908 |  | Added +1,000,309 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $78.4m | 14,485,533 |  | Added +1,920,642 |
| [LASALLE INVESTMENT MANAGEMENT SECURITIES LLC](/funds/1085601.md) | 2026-06-30 | $70.9m | 13,105,447 |  | Added +4,046,587 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $67.7m | 12,511,023 |  | Added +153,493 |
| [SOUTHEASTERN ASSET MANAGEMENT INC/TN/](/funds/807985.md) | 2026-06-30 | $47.0m | 8,696,434 |  | Added +2,223,117 |
| [Sumitomo Mitsui Trust Group, Inc.](/funds/1475365.md) | 2026-06-30 | $37.4m | 6,905,936 |  | Added +2,000,283 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $32.8m | 6,057,833 |  | Added +65,270 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $32.5m | 6,006,793 |  | Added +6,840 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $21.8m | 4,030,612 |  | Added +403,309 |
| [CENTERSQUARE INVESTMENT MANAGEMENT LLC](/funds/1725296.md) | 2026-06-30 | $19.4m | 3,580,271 |  | Added +328,499 |

## Recent filings

[All 736 filings](/companies/esrt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 18:26 ET | [SCHEDULE 13D](/filings/0000902664-26-004065.md) | Ownership report, active investor | 0000902664-26-004065 |
| 2026-08-06 | 16:52 ET | [10-Q](/filings/0001541401-26-000033.md) | Quarterly report, period 2026-06-30 | 0001541401-26-000033 |
| 2026-07-29 | 16:25 ET | [8-K](/filings/0001541401-26-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001541401-26-000030 |
| 2026-07-17 | 17:23 ET | [8-K](/filings/0001541401-26-000028.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001541401-26-000028 |
| 2026-06-02 | 06:02 ET | [8-K](/filings/0001541401-26-000026.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001541401-26-000026 |
| 2026-05-19 | 16:37 ET | [8-K](/filings/0001541401-26-000023.md) | 5.07 Shareholder vote results | 0001541401-26-000023 |
| 2026-05-07 | 16:27 ET | [10-Q](/filings/0001541401-26-000020.md) | Quarterly report, period 2026-03-31 | 0001541401-26-000020 |
| 2026-04-29 | 16:11 ET | [8-K](/filings/0001541401-26-000016.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001541401-26-000016 |
| 2026-04-15 | 16:24 ET | [8-K](/filings/0001541401-26-000013.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001541401-26-000013 |
| 2026-04-02 | 08:30 ET | [DEF 14A](/filings/0001104659-26-038890.md) | Proxy statement, period 2026-05-14 | 0001104659-26-038890 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001541401-26-000008.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bba18f9f-9419-44dd-ac3a-9ba9c0015911)

## About the filer

- CIK: 1541401
- Tickers: ESRT
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:39 ET. No prices; not investment advice.